IL-23IL-23

Back to Disease

May 2026

Journal Club Review: SOLSTICE Publication

April 2026

Journal Club Review: APEX Publication

April 2026

Journal Club Review: DISCOVER-2 Severe PsA Publication

February 2026

Medication Review: What is the Safety and Efficacy Profile of Guselkumab in Juvenile Psoriatic Arthritis?

February 2026

Medication Review: Anti-Drug Antibody Development With Guselkumab in Psoriasis, PsA & IBD

March 2026

SubQ Solutions: Induction and Maintenance in Moderately to Severely Active CD and UC

March 2026

What is the Importance of MRI in Assessing Axial Disease Manifestations in PsA?

February 2026

Medication Review: Laboratory Monitoring Recommendations for Guselkumab in PSO, PsA, and IBD

January 2026

Journal Club: Guselkumab Binds To CD64+ IL-23–Producing Myeloid Cells to Neutralize IL-23 Signals

February 2026

Medication Review: Safety and Efficacy of Guselkumab in the Treatment of CD and UC

sectionimg

dotsimg

Download the app and start using it now.

Download on the App Store

GET IT ON Google Play